Summary of the best evidence for non-drug management of diarrhea after laparoscopic cholecystectomy_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

CHEN Peiyun ¹ , LI Zihui ² , HUANG Houqiang ² ,  ZHENG Silin ²

1. School of Nursing, Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;
2. Department of Nursing, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;

Corresponding?author：

ZHENG Silin, Email: 1400223549@qq.com

Keywords：

laparoscopic cholecystectomy; diarrhea; non-drug management; summary of evidence

DOI：

10.7507/1007-9424.201911111

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To select and obtain the related evidence of non-drug management of diarrhea after laparoscopic cholecystectomy (LC) at home and abroad and summarize the best evidence.Methods We systematically searched the PubMed, Cochrane Library, British Medical Journal best clinical practice, JBI evidence-based Health Care Center database, CINAHL database, Scottish inter-college Guide Network, American Guide Network, Ontario Nursing Society of Canada website, British National Institute of Clinical Medicine, and Chinese Biomedical Literature Database. All evidences on the non-drug management of diarrhea in the LC patients, including guidelines, system evaluation, expert consensus, etc. were retrieved. The retrieval time was limited from the establishment of the databases to November 9, 2019. The quality of the literature was independently evaluated by 2 researchers, and the data were extracted from the standard literature according to the judgment of professionals.Results There were 15 literatures including 9 guidelines, 4 expert consensuses, and 2 systematic reviews. After the evaluation, 28 evidences for the non-drug management of diarrhea after LC were summarized.Conclusions The best evidences selected in this study could be applied to the practice of non-drug management of diarrhea after LC. However, the evidences should be selected according to the patients’ actual conditions and the individuation.

Citation： CHEN Peiyun, LI Zihui, HUANG Houqiang, ZHENG Silin. Summary of the best evidence for non-drug management of diarrhea after laparoscopic cholecystectomy. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(9): 1121-1127. doi: 10.7507/1007-9424.201911111 Copy

1.	朱佳杰, 于博文, 李鵬, 等. 膽囊切除術后綜合征的研究進展. 臨床肝膽病雜志, 2015, 31(10): 1730-1734.
2.	Fisher M, Spilias DC, Tong LK. Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants. ANZ J Surg, 2008, 78(6): 482-486.
3.	宋瑞梅, 施雁, 荀林娟, 等. 腹腔鏡膽囊切除術后腹瀉影響因素的研究進展. 解放軍護理雜志, 2018, 35(13): 46-48, 53.
4.	黃海燕, 米元元, 喻姣花, 等. 危重癥住院患者失禁相關性皮炎預防及護理的最佳證據總結. 護理學雜志, 2017, 32(21): 50-53.
5.	Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evidence: fine-tuning the 5S model into a 6S model. Evid Based Nurs, 2009, 12(4): 99-101.
6.	Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
7.	何克芝. 循證護理的理論與實踐程序. 護理學雜志, 2002, 17(12): 945-947.
8.	The Joanna Briggs Institute (JBI). (2017-07-15)[2018-08-29]. http//joannabriggs.org/research/critical-appraisal-tools.html.
9.	賀菊芳, 龔海軍, 張彩云, 等. 腸易激綜合征患者正念減壓療法干預的系統評價. 中國心理衛生雜志, 2018, 32(2): 106-111.
10.	舒小闖, 周淑萍, 陳春燕, 等. 益生菌治療腸易激綜合征隨機對照試驗的系統評價. 中國循證醫學雜志, 2012, 12(7): 840-847.
11.	McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet, 2016, 29(5): 549-575.
12.	Makharia G, Gibson P, Bai J, et al. World Gastroenterology Organisation Global Guidelines: Diet and the gut. J Clin Gastroenterol, 2018, 51(9): 755-768.
13.	Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J, 2019, 7(5): 583-613.
14.	Bai J, Ciacci C, Corazza GR, et al. World Gastroenterology Organisation Global Guidelines: Celiac disease. J Clin Gastroenterol, 2013, 47(2): 121-126.
15.	Internal Clinical Guidelines Team (UK). Coeliac disease: Recognition, assessment and management. NICE guideline 20. Retrieved from https://www.nice.org.uk/guidance/ng20.
16.	Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 2014, 63(8): 1210-1228.
17.	Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol, 2013, 108(5): 656-676.
18.	Song KH, Jung HK, Kim HJ, et al. Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition. J Neurogastroenterol Motil, 2018, 24(2): 197-215.
19.	Moayyedi P, Andrews CN, MacQueen G, et al. Canadian association of gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS). J Can Assoc Gastroenterol, 2019, 2(1): 6-29.
20.	Wu JC, Chan AO, Chan YW, et al. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements. Hong Kong Med J, 2017, 23(6): 641-647.
21.	Gwee KA, Gonlachanvit S, Ghoshal UC, et al. Second Asian consensus on irritable bowel syndrome. J Neurogastroenterol Motil, 2019, 25(3): 343-362.
22.	Casellas F, Burgos R, Marcos A, et al. Consensus document on exclusion diets in irritable bowel syndrome (IBS). Nutr Hosp, 2018, 35(6): 1450-1466.
23.	中華醫學會消化病學分會胃腸動力學組, 中華醫學會消化病學分會胃腸功能性疾病協作組. 中國功能性消化不良專家共識意見(2015 年, 上海). 中華消化雜志, 2016, 36(4): 217-229.
24.	王春青, 胡雁. JBI 證據預分級及證據推薦級別系統(2014 版). 護士進修雜志, 2015, 30(11): 964-967.
25.	Svensson JO, Gelin J, Svanvik J. Gallstones, cholecystectomy, and duodenogastric reflux of bile acid. Scand J Gastroenterol, 1986, 21(2): 181-187.
26.	Wilson P, Jamieson JR, Hinder RA, et al. Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. Surgery, 1995, 117(4): 421-428.
27.	Meshkinpour H, Mollot M. Sphincter of Oddi dysfunction and unexplained abdominal pain: clinical and manometric study. Dig Dis Sci, 1992, 37(2): 257-261.
28.	Evans PR, Dowsett JF, Bak YT, et al. Abnormal sphincter of Oddi response to cholecystokinin in postcholecystectomy syndrome patients with irritable bowel syndrome. The irritable sphincter. Dig Dis Sci, 1995, 40(5): 1149-1156.

1. 朱佳杰, 于博文, 李鵬, 等. 膽囊切除術后綜合征的研究進展. 臨床肝膽病雜志, 2015, 31(10): 1730-1734.
2. Fisher M, Spilias DC, Tong LK. Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants. ANZ J Surg, 2008, 78(6): 482-486.
3. 宋瑞梅, 施雁, 荀林娟, 等. 腹腔鏡膽囊切除術后腹瀉影響因素的研究進展. 解放軍護理雜志, 2018, 35(13): 46-48, 53.
4. 黃海燕, 米元元, 喻姣花, 等. 危重癥住院患者失禁相關性皮炎預防及護理的最佳證據總結. 護理學雜志, 2017, 32(21): 50-53.
5. Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evidence: fine-tuning the 5S model into a 6S model. Evid Based Nurs, 2009, 12(4): 99-101.
6. Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
7. 何克芝. 循證護理的理論與實踐程序. 護理學雜志, 2002, 17(12): 945-947.
8. The Joanna Briggs Institute (JBI). (2017-07-15)[2018-08-29]. http//joannabriggs.org/research/critical-appraisal-tools.html.
9. 賀菊芳, 龔海軍, 張彩云, 等. 腸易激綜合征患者正念減壓療法干預的系統評價. 中國心理衛生雜志, 2018, 32(2): 106-111.
10. 舒小闖, 周淑萍, 陳春燕, 等. 益生菌治療腸易激綜合征隨機對照試驗的系統評價. 中國循證醫學雜志, 2012, 12(7): 840-847.
11. McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet, 2016, 29(5): 549-575.
12. Makharia G, Gibson P, Bai J, et al. World Gastroenterology Organisation Global Guidelines: Diet and the gut. J Clin Gastroenterol, 2018, 51(9): 755-768.
13. Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J, 2019, 7(5): 583-613.
14. Bai J, Ciacci C, Corazza GR, et al. World Gastroenterology Organisation Global Guidelines: Celiac disease. J Clin Gastroenterol, 2013, 47(2): 121-126.
15. Internal Clinical Guidelines Team (UK). Coeliac disease: Recognition, assessment and management. NICE guideline 20. Retrieved from https://www.nice.org.uk/guidance/ng20.
16. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 2014, 63(8): 1210-1228.
17. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol, 2013, 108(5): 656-676.
18. Song KH, Jung HK, Kim HJ, et al. Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition. J Neurogastroenterol Motil, 2018, 24(2): 197-215.
19. Moayyedi P, Andrews CN, MacQueen G, et al. Canadian association of gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS). J Can Assoc Gastroenterol, 2019, 2(1): 6-29.
20. Wu JC, Chan AO, Chan YW, et al. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements. Hong Kong Med J, 2017, 23(6): 641-647.
21. Gwee KA, Gonlachanvit S, Ghoshal UC, et al. Second Asian consensus on irritable bowel syndrome. J Neurogastroenterol Motil, 2019, 25(3): 343-362.
22. Casellas F, Burgos R, Marcos A, et al. Consensus document on exclusion diets in irritable bowel syndrome (IBS). Nutr Hosp, 2018, 35(6): 1450-1466.
23. 中華醫學會消化病學分會胃腸動力學組, 中華醫學會消化病學分會胃腸功能性疾病協作組. 中國功能性消化不良專家共識意見(2015 年, 上海). 中華消化雜志, 2016, 36(4): 217-229.
24. 王春青, 胡雁. JBI 證據預分級及證據推薦級別系統(2014 版). 護士進修雜志, 2015, 30(11): 964-967.
25. Svensson JO, Gelin J, Svanvik J. Gallstones, cholecystectomy, and duodenogastric reflux of bile acid. Scand J Gastroenterol, 1986, 21(2): 181-187.
26. Wilson P, Jamieson JR, Hinder RA, et al. Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. Surgery, 1995, 117(4): 421-428.
27. Meshkinpour H, Mollot M. Sphincter of Oddi dysfunction and unexplained abdominal pain: clinical and manometric study. Dig Dis Sci, 1992, 37(2): 257-261.
28. Evans PR, Dowsett JF, Bak YT, et al. Abnormal sphincter of Oddi response to cholecystokinin in postcholecystectomy syndrome patients with irritable bowel syndrome. The irritable sphincter. Dig Dis Sci, 1995, 40(5): 1149-1156.

Previous Article
Surgical treatment of vertebral artery stenosis: a clinical analysis of 6 cases
Next Article
Effect of fast track surgery in perioperative period of hepatectomy: A meta analysis

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Summary of the best evidence for non-drug management of diarrhea after laparoscopic cholecystectomy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content